Charles River Laboratories Interna revenue and financials
$304.96Change from previous close: −1.87%Absolute change: −$5.81
In the fiscal year ended December 2025, Charles River Laboratories Interna reported revenue of $4.02B (−0.85% year over year). The net loss was $144.34M.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- −0.85%
- 2025 vs 2024
- Net margin
- -3.6%
- 2024: 0.5%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 738 | 735 | 684 | 620 | 761 | 547 | 481 | 441 | 318 | 317 |
| Depreciation and amortization | 403 | 362 | 314 | 304 | 266 | 235 | 198 | 162 | 131 | 127 |
| Capital expenditure | -219 | -233 | -319 | -325 | -229 | -167 | -141 | -140 | -82.4 | -55.3 |
| Investing cash flow | -209 | -245 | -563 | -608 | -1,438 | — | — | — | — | — |
| Financing cash flow | -537 | -551 | -85.5 | -42.4 | 673 | — | — | — | — | — |
| Share repurchases | -361 | -119 | -24.2 | -38.7 | -40.7 | -24.0 | -18.1 | -13.8 | -107 | -12.3 |
| Debt issued | — | — | — | 2,952 | — | — | — | — | — | — |
| Debt repaid | — | — | — | -2,933 | — | — | — | — | — | — |
| Effect of exchange rates | 18.8 | -17.5 | 8.0 | 25.6 | 17.7 | — | — | — | — | — |
| Net change in cash | 10.4 | -78.9 | 43.3 | -5.1 | 13.2 | — | — | — | — | — |
| Free cash flow | 518 | 502 | 365 | 295 | 532 | — | — | — | — | — |
| Levered free cash flow | 572 | 490 | 214 | 304 | 630 | — | — | — | — | — |